sLAG3 had an adjuvant effect on a DNA tumor vaccine, which maintained most 1-year old BALB-neuT transgenic mice tumor free, with markedly extended disease-free survival and reduced mammary adenocarcinoma tumor multiplicity. The gene discussed is LAG3; the disease is neoplasm.